Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PAD4 and Its Inhibitors in Cancer Progression and Prognosis
Di Zhu, Yu Lu, Yanming Wang, et al.
Pharmaceutics (2022) Vol. 14, Iss. 11, pp. 2414-2414
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Antibody discovery identifies regulatory mechanisms of protein arginine deiminase 4
Xin Zhou, Sophie Kong, Allison Maker, et al.
Nature Chemical Biology (2024) Vol. 20, Iss. 6, pp. 742-750
Open Access | Times Cited: 11
Structure–Activity Relationship of PAD4 Inhibitors and Their Role in Tumor Immunotherapy
Yijiang Jia, Renbo Jia, Ayijiang Taledaohan, et al.
Pharmaceutics (2024) Vol. 16, Iss. 3, pp. 335-335
Open Access | Times Cited: 5
NETosis in tumour microenvironment of liver: From primary to metastatic hepatic carcinoma
Yi Yang, Siyue Yu, Chao Lv, et al.
Ageing Research Reviews (2024) Vol. 97, pp. 102297-102297
Closed Access | Times Cited: 5
Liver ischemia reperfusion injury: Mechanisms, cellular pathways, and therapeutic approaches
Thiago Henrique Oliveira, Gleisy Kelly Neves Gonçalves
International Immunopharmacology (2025) Vol. 150, pp. 114299-114299
Closed Access
New structural scaffolds to enhance the metabolic stability of arginine-derived PAD4 inhibitors
Yijiang Jia, Sina Bahraminejad, Chenyao Jiang, et al.
Results in Chemistry (2025), pp. 102162-102162
Open Access
The emerging role of neutrophil extracellular traps in autoimmune and autoinflammatory diseases
Liuting Zeng, Xiang Wang, Wei Xiao, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access
PAD4 Inhibitor-Loaded Magnetic Fe3O4 Nanoparticles for Magnetic Targeted Chemotherapy and Magnetic Resonance Imaging of Lung Cancer
Yu Lu, Xin Wang, Yijiang Jia, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 3031-3044
Open Access
PADI4 facilitates stem‐like properties and cisplatin resistance through upregulating PRMT2/IDs family in oesophageal squamous cell carcinoma
Zeyu Wang, Hao Wu, Zhaoxing Li, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 3
Open Access
Targeting neutrophil extracellular traps: A novel strategy in hematologic malignancies
Rongxing Liu, Jin Zhang, Fernando Rodrigues‐Lima, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116334-116334
Open Access | Times Cited: 4
Immobilized PAD4 enzyme on magnetic nanoparticles for screening natural inhibitors from traditional Chinese medicines
Zeyuan Zhao, Chenyang Wang, Juanjuan Zhao, et al.
Talanta (2024) Vol. 278, pp. 126492-126492
Closed Access | Times Cited: 4
PAD2: A potential target for tumor therapy
Yi Teng, Yuhang Chen, Xinyi Tang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 5, pp. 188931-188931
Closed Access | Times Cited: 11
A β-Carboline Derivate PAD4 Inhibitor Reshapes Neutrophil Phenotype and Improves the Tumor Immune Microenvironment against Triple-Negative Breast Cancer
Di Zhu, Yu Lu, Zhanchao Yan, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 10, pp. 7973-7994
Closed Access | Times Cited: 3
Inhibition of neutrophil extracellular trap formation alleviates vascular dysfunction in type 1 diabetic mice
Chao Liu, Srilakshmi Yalavarthi, Ajay Tambralli, et al.
Science Advances (2023) Vol. 9, Iss. 43
Open Access | Times Cited: 9
Neutrophil-Derived Peptidyl Arginine Deiminase Activity Contributes to Pulmonary Emphysema by Enhancing Elastin Degradation
Mark P. Murphy, David Hunt, Malcolm Herron, et al.
The Journal of Immunology (2024) Vol. 213, Iss. 1, pp. 75-85
Open Access | Times Cited: 2
Highly-tumor-targeted PAD4 inhibitors with PBA modification inhibit tumors in vivo by specifically inhibiting the PAD4-H3cit-NETs pathway in neutrophils
Di Zhu, Lu Yu, Bo Hu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115619-115619
Open Access | Times Cited: 6
New insights into cancer: MDM2 binds to the citrullinating enzyme PADI4
Salomé Araujo‐Abad, Bruno Rizzuti, Adrián Villamarin‐Ortiz, et al.
Protein Science (2023) Vol. 32, Iss. 8
Open Access | Times Cited: 6
Deimination in epidermal barrier and hair formation
Marie‐Claire Méchin, Michel Simon
Philosophical Transactions of the Royal Society B Biological Sciences (2023) Vol. 378, Iss. 1890
Open Access | Times Cited: 6
H3 histone methylation landscape in male urogenital cancers: from molecular mechanisms to epigenetic biomarkers and therapeutic targets
Liliana Burlibașa, Alina-Teodora Nicu, Mariana Carmen Chifiriuc, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 5
The intrinsically disordered, epigenetic factor RYBP binds to the citrullinating enzyme PADI4 in cancer cells
Salomé Araujo‐Abad, María Fuentes-Baile, Bruno Rizzuti, et al.
International Journal of Biological Macromolecules (2023) Vol. 246, pp. 125632-125632
Open Access | Times Cited: 5
Mitosis targeting in non-small lung cancer cells by inhibition of PAD4
Xiangmei Wu, Liujia Chan, Di Zhu, et al.
Heliyon (2024) Vol. 10, Iss. 6, pp. e27313-e27313
Open Access | Times Cited: 1
Predicting the immunity landscape and prognosis with an NCLs signature in liver hepatocellular carcinoma
Zhangxin Ji, Chenxu Zhang, Jingjing Yuan, et al.
PLoS ONE (2024) Vol. 19, Iss. 4, pp. e0298775-e0298775
Open Access | Times Cited: 1
Screening of peptidyl arginine deiminase 4 inhibitors in traditional herbal medicines
Yanfeng Li, Chunli Gao, Juanjuan Zhao, et al.
Fitoterapia (2024) Vol. 177, pp. 106095-106095
Closed Access | Times Cited: 1
Sorafenib-induced macrophage extracellular traps via ARHGDIG/IL4/PADI4 axis confer drug resistance through inhibiting ferroptosis in hepatocellular carcinoma
Xiangbo Huang, Nan Yi, Pengfei Zhu, et al.
Biology Direct (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1
Small molecule activates citrullination through targeting PAD2
Xue Zhang, Mengzhen Shen, Huimin Zhu, et al.
Philosophical Transactions of the Royal Society B Biological Sciences (2023) Vol. 378, Iss. 1890
Open Access | Times Cited: 4
Neutrophil PAD4 Expression and Its Pivotal Role in Assessment of Alcohol-Related Liver Disease
Anna Rycyk, Beata Kasztelan‐Szczerbińska, Halina Cichoż‐Lach, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7597-7597
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top